Next Article in Journal
Targeted Urine Metabolomics for Monitoring Renal Allograft Injury and Immunosuppression in Pediatric Patients
Next Article in Special Issue
Pornography Use in Adolescents and Its Clinical Implications
Previous Article in Journal
Diagnostic Performances of Urinary Methylmalonic Acid/Creatinine Ratio in Vitamin B12 Deficiency
Previous Article in Special Issue
Creating and Validating the DESEA Questionnaire for Men and Women
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clinical Features Associated with Female Genital Mutilation/Cutting: A Pilot Longitudinal Study

by
Georgios Paslakis
1,2,*,
Josep M. Farré
3,
Iris Tolosa-Sola
3,
Alba Palazón-Llecha
3,
Helena Domínguez-Cagnon
3,
Maria Jiménez
3,
Berta Martínez Rosselló
3,
Pere Barri-Soldevila
4 and
Gemma Mestre-Bach
3,5,*
1
Toronto General Hospital, University Health Network, Toronto, ON M5G 2C4, Canada
2
Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada
3
Department of Psychiatry, Psychology and Psychosomatics, Dexeus University Hospital, 08028 Barcelona, Spain
4
Department of Obstetrics, Gynecology, and Reproduction, Dexeus University Hospital, 08028 Barcelona, Spain
5
Facultad de Ciencias de la Salud, Universidad Internacional de La Rioja, 26006 La Rioja, Spain
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(8), 2340; https://doi.org/10.3390/jcm9082340
Submission received: 16 June 2020 / Revised: 16 July 2020 / Accepted: 17 July 2020 / Published: 22 July 2020
(This article belongs to the Special Issue Sexuality and Sexual Dysfunctions)

Abstract

:
(1) Background: Female genital mutilation/cutting (FGM/C) is associated with physical and psychological complications. However, there is scarce literature on how women with FGM/C respond to treatment interventions. (2) Methods: In the present pilot longitudinal study, we assessed changes in general psychopathology (Symptom Check List-90-R), sexual functioning and distress (Female Sexual Function Index, Female Sexual Distress Scale-Revised, and Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) female sexual dysfunction criteria), body image (Body Shape Questionnaire), and sexual body image (Female Genital Self-Image Scale) in a sample of n = 15 women with FGM/C before and after reconstructive surgery. (3) Results: Sexual distress was significantly improved following surgery. We also observed an improvement in general psychopathology and genital self-image. However, sexual function was not improved. (4) Conclusions: These results provide evidence for the benefits of reconstructive surgery on sexual distress in women with FGM/C. The impact of surgery on sexual function cannot be conclusively evaluated.

1. Introduction

The World Health Organization has defined female genital mutilation/cutting (FGM/C) as any intentional procedure to partly or entirely remove external female genitalia, or any injury to the female genitalia that is non-therapeutic [1]. FGM/C has been classified into four different types depending on the extent to which genital tissue is removed. FGM/C is a deeply rooted cultural and still ongoing practice in a significant number of countries across Africa, the Middle East, Asia, and the Pacific. However, with migration, it has spread to countries like Spain. In Spain, there are currently different scenarios to consider: (1) girls or adult women who already arrive in the country with FGM/C; (2) girls born in Spain, who undergo FGM/C during a holiday or long-term trip to their parents’ country of origin, regardless of parental consent to the procedure; and (3) girls born in Spain, who undergo FGM/C on Spanish territory or in other European countries, although there are no records of this scenario since the 1990s [2].
FGM/C is performed for different reasons, but usually as a ritual representing the shift to womanhood and obtaining legitimacy as new member of the community [2,3,4]. Nonetheless, it is considered a violation of human rights of the affected individuals [1] and, in Europe, several initiatives and policies have been formed to address it [5].
From a sexual medicine perspective, women who suffered FGM/C often show a burden of short- and long-term gynecological and obstetric impairments, including urinary retention, genital scarring, infections, bacterial vaginosis, perinatal complications and menstrual difficulties [6,7,8,9,10,11,12,13]. Relatedly, FGM/C is also associated with sexual function impairments [10,14]. A reduction in sexual satisfaction, along with less sexual activity and sensitivity, and female sexual dysfunctions, especially genito-pelvic pain/penetration and female orgasmic disorders have been reported by women with FGM/C [15,16].
Although many authors uphold the negative sexual and physical impact of FGM/C, research focused on the correlates of psychopathology and FGM/C is still in its nascent stages [17]. Most commonly identified manifestations of psychological impairments include negative self-image, depression, anxiety, somatization, and posttraumatic stress disorder [17,18,19,20,21,22,23,24]. In a recent comprehensive literature review, 14 of the 16 included studies reported an association between FGM/C and at least one adverse mental health outcome [25].
Different options for reconstruction of the female genital after FGM/C have been proposed, such as defibulation, removal of cysts, reconstruction of clitoris and labia, neuromas, and scar tissue, although clitoral reconstruction (CR) has been the most widely used [24,26]. CR has been shown to improve both genital anatomy and sexual function, including favorable changes in genital self-image [10,27,28,29,30]. There is some evidence showing that CR may also improve gynecologic and obstetric outcomes [31], although it may not improve urological complications [32]. However, the impact of CRon the psychological and sexual well-being of women with FGM/C is largely uninvestigated. Preliminary studies in this area have reported reduced depression and sexual distress levels and possible improvements in body image after CR [16,24,33]. However, it appears that genital self-image is not significantly improved after CR [16]. More studies are needed as genital self-image has been shown to be associated with sexual function [34,35,36].
Several barriers related to economic and (infra-)structural aspects (e.g., costs or the distance to specialized health care facilities), socio-cultural factors (e.g., cultural taboos), concerns about the quality of care, and fears of legal sanctions have been identified to limit health care utilization by women who have suffered FGM/C [37]. Furthermore, the perception of one’s genital image as “ugly” due to FGM/C may also lead affected women to abstain from seeking health care support such as gynecological screenings [38].
In the present study, a series of sexual and psychopathological variables including body image and genital self-image were assessed in women who had suffered FGM/C. The aim of the study was to re-evaluate sexual function and psychological well-being in these women after they had undergone CR. Our hypothesis was that CR would lead to an amelioration in all aspects under investigation.

2. Experimental Section

2.1. Participants and Procedure

The present longitudinal study included n = 43 women with Type I and II FGM/C who sought CR at the Department of Obstetrics, Gynecology, and Reproduction at our hospital. The study was conducted in a private hospital, located in an urban area of Spain, although the entire intervention was covered by a charitable foundation, meaning patients did not have to incur any financial costs. All participants included in the study were living in Spain and were fluent in Spanish. They were referred by their primary health care physicians or sought treatment themselves. All were consecutive referrals for assessment and treatment between March 2015 and January 2020.
For this study, FGM/C types were categorized according to the WHO classification by a gynecologist who is an expert in this field [1]. Type I, also known as clitoridectomy, refers to the partial or total removal of the clitoris, and only in some cases, only the removal of the prepuce. Type II, also known as excision, includes the partial or total removal of the clitoris and the labia minora, with or without excision of the labia majora.
Inclusion criteria were to be women, between the ages of 18 and 45 (except for two cases outside this age range who underwent reconstructive surgery based on the clinical indication set by gynecologists), and being sexually active (to determine the presence of sexual dysfunctions or distress). Exclusion criteria were having an intellectual disability or severe mental disorder, being pregnant, and having a mutilation considered to not be eligible for CR. Patients who met inclusion criteria were assigned to a therapist at the Department of Psychiatry, Psychology and Psychosomatics at our hospital and were considered potential participants for this study.
All participants were assessed in a face-to-face clinical interview by a clinical psychologist before CR and a total of n=15 participants were also assessed 1 year after surgery. The remaining patients did not attend the follow-up session after one year post-CR. Sociodemographic and clinical information was assessed at baseline and the 1-year follow-up, as required. Patients also individually completed all questionnaires (requiring approximately 40 min) at these two time points (Figure 1 includes the timeline of the present study) (see Figure 1).

2.2. CR Procedure

CR consists of uncovering the remaining clitoris and placing it externally as close to the vagina as possible. The procedure consists of first removing scar tissue from the skin to expose the clitoris. When the residual clitoris is recognized, the clitoris is dissected from bulbocavernosus muscles in order to obtain lateral mobility and the suspensory ligament is sectioned. The anchorage of the gland is performed with Vycril sutures that encroach both the pubic periosteum and the ventral base of the clitoris. The skin is closed with interrupted 3–0 stitches. Patients are discharged one day after surgery and are required to attend checkup visits. The patient is instructed on how to perform daily wound care the first month following surgery. Sexual intercourse is allowed 3 months after surgery and a final evaluation is made at 1 year after CR.

2.3. Measures

2.3.1. Psychopathology: Symptom Check List-90-R (SCL-90-R)

This 90-item questionnaire featuring a five-point Likert scale format was used to evaluate nine symptom dimensions (somatization, obsession-compulsion, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism) and three global indices (distress, severity, and positive symptoms) [39]. The Spanish validation has shown adequate internal consistency (0.76 and 0.98) [40].

2.3.2. Sexual Functioning: Female Sexual Function Index (FSFI)

The FSFI [41] is a 19-item self-report measure which assesses sexual function in females. It is made up of six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. It has been shown to have good psychometric properties and clinical utility. Next to the individual domains, a total score is also calculated. The Spanish version was validated by Blumel et al. [42]. Sexual dysfunction was assessed by adding the scores from the different domains of the FSFI.

2.3.3. Sexual Distress: Female Sexual Distress Scale-Revised (FSDS-R)

The FSDS-R [43] is a 13-item questionnaire which assesses different components of sexual distress in women over the last 4 weeks. Items on the FSDS-R are scored using a five-point Likert-type scale (never (0), rarely (1), occasionally (2), frequently (3), or always (4)) and provide a total score; higher scores indicate higher levels of sexual distress. The original version has demonstrated adequate reliability (α =0.87 to α = 0.93) and high test–retest reliability (r = 0.74 to r = 0.86) [43].

2.3.4. Sexual Functioning: Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

DSM-5 female sexual dysfunction criteria were used in the present study [44]. The DSM-5 recognizes the following disorders as female sexual dysfunctions: female sexual interest or arousal disorder (mainly characterized by absent or reduced interest in sexual activity, sexual or erotic thoughts or fantasies, and sexual excitement or pleasure during sexual activity or to any internal or external sexual or erotic cues); female orgasmic disorder (characterized by a marked delay in, infrequency, or absence of orgasm and/or reduced intensity of orgasmic sensations); and genito-pelvic pain or penetration disorder (mainly difficulties in vaginal penetration or vulvovaginal or pelvic pain during intercourse).

2.3.5. Body Shape: Body Shape Questionnaire (BSQ)

The BSQ [45] evaluates body dissatisfaction related to body self-perception. It comprises 34 items with six possible responses and it explores four factors: body dissatisfaction, fear of gaining weight, feelings of low self-esteem related to appearance, and desire to lose weight. A total score is calculated. BSQ has shown high reliability (Cronbach’s alpha between 0.95 and 0.97). The adapted version to Spanish population was used in the present study [46].

2.3.6. Sexual Body Image: Female Genital Self-Image scale (FGSI)

This is a reliable and valid measure to assess female genital self-image [47]. It consists of seven items related to women’s feelings and beliefs about their own genitals, and it uses a 4-point response scale: strongly agree, agree, disagree, and strongly disagree. A total score is calculated. The scale was found to have adequate reliability (α = 0.88). Moreover, questionnaire scores were found to be positively associated to sexual function [47].

2.3.7. Davidson Trauma Scale (DTS)

The DTS [48] is a 17-item self-report instrument. It is used to assess the 17 DSM-IV symptoms of post-traumatic stress disorder. Items are rated on 5-points frequency (0 “not at all” to 4 “every day”) and severity scales (0 “not at all distressing” to 4 “extremely distressing”). A cut-off score of 40 demonstrated a sensitivity of 0.69 and a specificity of 0.95 [48].

2.3.8. Other Sociodemographic, Sexual and Clinical Variables

Sociodemographic variables, sexual, and psychiatric history were assessed by means of a semi-structured face-to-face clinical interview.

2.4. Statistical Analyses

All statistical analyses were performed using SPSS (IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp.). Appropriate descriptive statistics were calculated for all sociodemographics, sexual and psychiatric history, DSM-5 sexual disorders, mutilation type, and all questionnaires applied at baseline. Paired T-Tests were performed to investigate changes in all measures under investigation from baseline to follow-up (1 year postoperatively). The level of significance was set at p ≤ 0.05.

2.5. Ethics

The present study was carried out in accordance with the latest version of the Declaration of Helsinki. The Hospital Clinical Research Ethics Committee approved the study, and signed informed consent was obtained from all participants.

3. Results

3.1. Demographics

Data from a total of n = 43 women with FGM/C and a mean age of 27.88 ± 7.33 years were analyzed in this study. One patient underwent reconstructive surgery at age 17 and another one at age 48 based on clinical (gynecological) judgment. Of these women, n = 41 had suffered a type II FGM/C, and n = 2 a type I FGM/C. Place of birth was West Africa in most (n = 30) of cases. The majority of these women were single (n = 26, 60.5%) and had no children (n = 26, 60.5%). Most of them had high school education (n = 26, 60.5%) and were employed at the time of study participation (n = 29, 67.4%). The vast majority of women also had no previous psychiatric history (n = 38, 88.4%). Demographics are shown in Supplementary Table S1.
Of these n = 43 women and n = 15 were re-assessed post-operatively. Their mean age was 28.80 ± 7.41 years. Most of these women (73.3%) were single and had no children (73.3%). No psychiatric history was reported in 86.7% (n = 13) of the women. Demographics of the women who took part in the longitudinal investigation are presented in Table 1.

3.2. Baseline Measures

Based on clinical interviews to assess sexual disorders according to the DSM-5, more than half of the cohort fulfilled the criteria for sexual interest/arousal disorder (n = 25, 58.1%), and even more reported symptoms of an orgasmic disorder (n = 30, 69.8%). However, the percentage of women with genito-pelvic pain or penetration disorder (n = 17, 39.5%) was lower than the percentage of women who denied symptoms of this kind.
Results were similar among women in the longitudinal cohort; sexual interest/arousal disorder and orgasmic disorder were again the most prevalent symptoms (n = 8, 53.3% and n = 10, 66.7%, respectively), while n = 5 women reported genito-pelvic pain or penetration disorder (33.3%) (see Table 2).
The rest of the scores obtained for n = 43 women during the pre-surgical evaluation are displayed in supplementary Table S2.

3.3. Post-Operative Measures

Only n = 15 women returned to our unit one year after the CR. We attempted to contact women and ask for the reasons for refraining from their re-assessment appointments. Reasons were mainly having moved to another country for work or due to family issues or having found a job and not being able to accommodate medical visits.
In the group of women who were re-examined, psychological well-being, as measured by the SCL-90-R, was significantly improved in five of the nine subdomains (somatization, interpersonal sensitivity, depression, phobic anxiety, and paranoid ideation). All global indices of psychological distress were also significantly improved (see Table 3).
There was a highly significant improvement in FSDS-R scores as a measure for sexual distress (p < 0.001; see Table 3). However, all sexual function subscales of the FSFI, including sexual satisfaction, did not significantly improve (see Table 3).
Finally, while body shape concerns were not significantly different during the second assessment, there was a significant improvement in genital self-image (p = 0.02) (see Table 3).
Effect sizes for significant differences ranged from 0.56 to 1.22 (Cohen’s d), the majority being medium effect sizes with the exception of sexual distress (Cohen’s d = 1.22) (Table 3).

4. Discussion

The present study analyzed whether sexual function, sexual distress, body image and genital self-image, as well as general psychopathology in women with FGM/C improved after CR. We hypothesized that all of the assessed measures would significantly improve following surgery. Our hypotheses were partially supported.
As a main finding, a significant decrease in sexual distress after CR was noted (p < 0.001, Cohen’s d = 1.22). Thus, the highly statistically significant difference observed with regard to this aspect may be considered as evidence for the benefits of CR in women with FGM/C. On the other hand, sexual function did not improve. Despite a reduction in all FSFI scores, suggesting an improvement in sexual function after genital reconstruction, the differences were not statistically significant. This could either be cautiously interpreted as an indication that sexual distress is significantly improved regardless of recovery of sexual function or may be attributed to the small number of women assessed at follow-up (underpowered sample to detect significant changes in sexual function). Previous evidence on sexual function after CR is limited overall. However, some studies in this area suggest that CR might be beneficial for improving sexual function and pain [28,29,49,50]. A previous study in 12 women with FGM/C using the FSFI found an improvement in all dimensions except lubrication [10]. Interestingly, the mean total score in the post evaluation in that study was >23 [10], similar to the one we obtained here (23.84). Therefore, the authors concluded that FSFI is a suitable psychometric tool for conducting a standardized assessment of sexual function in women with FGM/C. A recent systematic review, which has included 62 studies (5829 women), has reported that up to 22% of women with FGM/C showed worsening of sexual function after CR [51].
Previous studies hypothesized that women’s general perception of their bodies may extend to different parts of the body, such as the genitals [52,53]. To examine inferences between body shape perception and genital self-image, both aspects were simultaneously assessed in the present study. A non-significant increase in satisfaction with body shape and a significant improvement in genital self-image were observed after CR. CR directly affects the genitals; it is therefore not surprising that there is an improvement in genital self-perception. At the same time, our finding points towards a lack of interdependence of the two concepts: improvement in genital self-image does not go along with an impact on body image perception. Again, the small cohort of this pilot study at follow-up should be considered while interpreting these results. To the best of our knowledge, only one previous case study assessed female genital self-image in a woman with FGM/C, showing a worsening in clitoral self-image after CR [16]. Previous studies assessing female genital self-image have observed that the dissatisfaction with one’s genitals may reduce the frequency of gynecological examinations [54]. In light of our finding and the critical observation by Demaria et al. [54], CR may contribute to better health care, which should be taken into account by health professionals providing care in women with FGM/C.
Finally, a significant overall improvement was evident when comparing general psychopathology features in women with FGM/C before and after CR (medium effect sizes Cohen’s d), although this improvement cannot be causally attributed to the surgical intervention.
Overall, as it is not yet clear if the intended benefits of CR outweigh associated risks [55], caution should be applied in interpreting the present findings.

Strengths, Limitations and Future Research

This study longitudinally evaluated a series of clinical aspects in women with FGM/C using validated psychometric tools. Our pilot study contributes to a further understanding of how CR might influence the well-being of these patients.
However, there are some drawbacks that should be highlighted. Our sample size was small, thus has limiting statistical power. Attrition to follow ups is a relevant limitation in studies of the kind. Future studies would be able to draw more specific conclusions by including large sample sizes and controlling for confounding variables. It remains unclear which individual and socio-cultural factors might be limiting adherence to medical follow-ups; tailored plans to prevent attrition need to be implemented. All data used in this study were collected from individuals who were voluntarily attending treatment and agreed to participate. Hence, the generalizability of our results to the entire population of women with FGM/C is limited. Additionally, despite our attempt to use a combined method of clinical interviewing and self-report to overcome biases in the evaluation, both procedures could be subject to a high degree of social and cultural desirability bias. Finally, a post-operative clinical interview based on the DSM-5 criteria could not be conducted in all patients, which should be considered a relevant limitation of the study.

5. Conclusions

Taken together, there are potential benefits of CR regarding sexual distress and genital self-image in women with FGM/C. However, the risks of the intervention must be taken into account and further research in this field is needed to determine the most adequate and effective interventions for women with FGM/C.

Supplementary Materials

The following are available online at https://www.mdpi.com/2077-0383/9/8/2340/s1, Table S1: Sample characteristics, Table S2: Baseline measures of psychological well-being, depression, anxiety, sexual distress, sexual function, body image, genital self-image, and trauma scores in women with FGM/C.

Author Contributions

Conceptualization, J.M.F. and G.M.-B.; Data curation, G.P. and G.M.-B.; Formal analysis, G.P.; Investigation, J.M.F., I.T.-S., P.B.-S. and G.M.-B.; Methodology, I.T.-S., A.P.-L., H.D.-C., M.J., B.M.R., P.B.-S. and G.M.-B.; Project administration, J.M.F. and G.M.-B.; Supervision, J.M.F., I.T.-S. and G.M.-B.; Writing—original draft, G.P., A.P.-L. and G.M.-B. All authors have read and agreed to the published version of the manuscript.

Funding

Fundación Dexeus Salud de la Mujer financed the intervention in this research. Mestre-Bach was supported by a postdoctoral grant from FUNCIVA. G.P. was supported by the Loretta Anne Rogers Chair in Eating Disorders Fund at University Health Network and the University of Toronto.

Acknowledgments

We thank Rebeca Sáez and Marta Gallostra for their contribution by managing each patient visit to the two departments of our hospital.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. WHO. Eliminating Female Genital Mutilationan Interagency Statement-OHCHR, UNAIDS, UNDP, UNECA, UNESCO, UNFPA, UNHCR, UNICEF, UNIFEM, WHO; WHO—World Health Organization: Geneva, Switzerland, 2008; p. 48. [Google Scholar]
  2. Kaplan Marcusán, A.; Moreno Navaro, J.; Pérez Jarauta, M.J.; Mutilación Genital Femenina (MGF). Manual Para Profesionales—Fuentes Documentales—Bienestar y Protección Infantil; Universidad Autónoma de Barcelona: Barcelona, Spain, 2010. [Google Scholar]
  3. UNICEF. United Nations Children’s Fund, Female Genital Mutilation/Cutting: A Global Concern; UNICEF: New York, NY, USA, 2016. [Google Scholar]
  4. Calder, B.L.; Brown, Y.M.R.; Rae, D.I. Female circumcision/genital mutilation: Culturally sensitive care. Health Care Women Int. 1993, 14, 227–238. [Google Scholar] [CrossRef]
  5. Baillot, H.; Murray, N.; Connelly, E.; Howard, N. Addressing female genital mutilation in Europe: A scoping review of approaches to participation, prevention, protection, and provision of services. Int. J. Equity Health 2018. [Google Scholar] [CrossRef] [PubMed]
  6. Berg, R.C.; Underland, V. The obstetric consequences of female genital mutilation/cutting: A systematic review and meta-analysis. Obstet. Gynecol. Int. 2013, 2013, 1–15. [Google Scholar] [CrossRef] [PubMed]
  7. Berg, R.C.; Underland, V.; Odgaard-Jensen, J.; Fretheim, A.; Vist, G.E. Effects of female genital cutting on physical health outcomes: A systematic review and meta-analysis. BMJ Open 2014. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Reisel, D.; Creighton, S.M. Long term health consequences of Female Genital Mutilation (FGM). Maturitas 2015, 80, 48–51. [Google Scholar] [CrossRef] [PubMed]
  9. Elneil, S. Female sexual dysfunction in female genital mutilation. Trop. Doct. 2016, 46, 2–11. [Google Scholar] [CrossRef] [Green Version]
  10. Vital, M.; De Visme, S.; Hanf, M.; Philippe, H.J.; Winer, N.; Wylomanski, S. Using the Female Sexual Function Index (FSFI) to evaluate sexual function in women with genital mutilation undergoing surgical reconstruction: A pilot prospective study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016. [Google Scholar] [CrossRef]
  11. Abdel-Aleem, M.A.; Elkady, M.M.; Hilmy, Y.A. The relationship between female genital cutting and sexual problems experienced in the first two months of marriage. Int. J. Gynecol. Obstet. 2016. [Google Scholar] [CrossRef]
  12. Esho, T.; Kimani, S.; Nyamongo, I.; Kimani, V.; Muniu, S.; Kigondu, C.; Ndavi, P.; Guyo, J. The “heat” goes away: Sexual disorders of married women with female genital mutilation/cutting in Kenya. Reprod. Health 2017. [Google Scholar] [CrossRef] [Green Version]
  13. Rouzi, A.A.; Berg, R.C.; Sahly, N.; Alkafy, S.; Alzaban, F.; Abduljabbar, H. Effects of female genital mutilation/cutting on the sexual function of Sudanese women: A cross-sectional study. Am. J. Obstet. Gynecol. 2017, 217, 62.e1–62.e6. [Google Scholar] [CrossRef]
  14. Biglu, M.H.; Farnam, A.; Abotalebi, P.; Biglu, S.; Ghavami, M. Effect of female genital mutilation/cutting on sexual functions. Sex. Reprod. Healthc. 2016, 10, 3–8. [Google Scholar] [CrossRef] [PubMed]
  15. Mazloomdoost, D.; Pauls, R.N. A comprehensive review of the clitoris and its role in female sexual function. Sex. Med. Rev. 2015, 3, 245–263. [Google Scholar] [CrossRef] [PubMed]
  16. Mestre-Bach, G.; Tolosa-Sola, I.; Barri-Soldevila, P.; Jiménez-Bonora, M.; Lasheras, G.; Farré, J.M. Clinical, sexual and psychopathological changes after clitoral reconstruction in a type II female genital mutilation/cutting: A case report. Afr. J. Reprod. Health 2019, 23, 154–162. [Google Scholar] [CrossRef] [PubMed]
  17. Whitehorn, J.; Ayonrinde, O.; Maingay, S. Female genital mutilation: Cultural and psychological implications. Sex. Relatsh. Ther. 2002, 17, 161–170. [Google Scholar] [CrossRef]
  18. Kizilhan, J.I. Impact of psychological disorders after female genital mutilation among Kurdish girls in Northern Iraq. Eur. J. Psychiatry 2011, 25, 92–100. [Google Scholar] [CrossRef]
  19. Chibber, R.; El-Saleh, E.; El Harmi, J. Female circumcision: Obstetrical and psychological sequelae continues unabated in the 21st century. J. Matern. Neonatal Med. 2011, 24, 833–836. [Google Scholar] [CrossRef]
  20. Khodabakhshi Koolaee, A.; Pourebrahim, T.; Mohammadmoradi, B.; Hameedy, M. The comparison of marital satisfaction and mental health in genital mutilated females and non-genital mutilated females. Int. J. High. Risk Behav. Addict. 2012. [Google Scholar] [CrossRef] [Green Version]
  21. Smith, H.; Stein, K. Psychological and counselling interventions for female genital mutilation. Int. J. Gynaecol. Obstet. 2017, 136, 60–64. [Google Scholar] [CrossRef] [Green Version]
  22. Ahmed, M.R.; Shaaban, M.M.; Meky, H.K.; Amin Arafa, M.E.; Mohamed, T.Y.; Gharib, W.F.; Ahmed, A.B. Psychological impact of female genital mutilation among adolescent Egyptian girls: A cross-sectional study. Eur. J. Contracept. Reprod. Heal. Care 2017. [Google Scholar] [CrossRef]
  23. Köbach, A.; Ruf-Leuschner, M.; Elbert, T. Psychopathological sequelae of female genital mutilation and their neuroendocrinological associations. BMC Psychiatry 2018. [Google Scholar] [CrossRef] [Green Version]
  24. Buggio, L.; Facchin, F.; Chiappa, L.; Barbara, G.; Brambilla, M.; Vercellini, P. Psychosexual consequences of female genital mutilation and the impact of reconstructive surgery: A narrative review. Heal. Equity 2019, 3, 36–46. [Google Scholar] [CrossRef] [PubMed]
  25. Abdalla, S.M.; Galea, S. Is female genital mutilation/cutting associated with adverse mental health consequences? A systematic review of the evidence. BMJ Glob. Heal. 2019. [Google Scholar] [CrossRef] [PubMed]
  26. Sigurjonsson, H.; Jordal, M. Addressing Female Genital Mutilation/Cutting (FGM/C) in the era of clitoral reconstruction: Plastic surgery. Curr. Sex. Heal. Reports 2018, 10, 50–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Paterson, L.Q.P.; Davis, S.N.; Binik, Y.M. Female genital mutilation/cutting and orgasm before and after surgical repair. Sexologies 2012, 21, 3–8. [Google Scholar] [CrossRef]
  28. Foldès, P.; Cuzin, B.; Andro, A. Reconstructive surgery after female genital mutilation: A prospective cohort study. Lancet 2012, 380, 134–141. [Google Scholar] [CrossRef]
  29. Ouédraogo, C.M.R.; Madzou, S.; Touré, B.; Ouédraogo, A.; Ouédraogo, S.; Lankoandé, J. Practice of reconstructive plastic surgery of the clitoris after genital mutilation in Burkina Faso. about 94 cases. Ann. Chir. Plast. Esthet. 2013, 58, 208–215. [Google Scholar] [CrossRef] [PubMed]
  30. Mañero, I.; Labanca, T. Clitoral reconstruction using a vaginal graft after female genital mutilation. Obstet. Gynecol. 2018, 131, 701–706. [Google Scholar] [CrossRef]
  31. Okusanya, B.O.; Oduwole, O.; Nwachuku, N.; Meremikwu, M.M. Deinfibulation for preventing or treating complications in women living with type III female genital mutilation: A systematic review and meta-analysis. Int. J. Gynaecol. Obstet. 2017, 136, 13–20. [Google Scholar] [CrossRef] [Green Version]
  32. Effa, E.; Ojo, O.; Ihesie, A.; Meremikwu, M.M. Deinfibulation for treating urologic complications of type III female genital mutilation: A systematic review. Int. J. Gynaecol. Obstet. 2017, 136, 30–33. [Google Scholar] [CrossRef] [Green Version]
  33. Mestre-Bach, G.; Tolosa-Sola, I.; Rodríguez, I.; Barri-Soldevila, P.; Lasheras, G.; Farré, J.M. Changes in sexual distress, depression and sexual function after clitoral reconstruction in women with female genital mutilation/cutting. Int. J. Sex. Heal. 2018, 30, 412–421. [Google Scholar] [CrossRef]
  34. Berman, L.A.; Berman, J.; Miles, M.; Pollets, D.; Powell, J.A. Genital self-image as a component of sexual health: Relationship between genital self-image, female sexual function, and quality of life measures. J. Sex. Marital Ther. 2003. [Google Scholar] [CrossRef] [PubMed]
  35. Schick, V.R.; Calabrese, S.K.; Rima, B.N.; Zucker, A.N. Genital appearance dissatisfaction: Implications for women’s genital image self-consciousness, sexual esteem, sexual satisfaction, and sexual risk. Psychol. Women Q. 2010, 34, 394–404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Barbara, G.; Facchin, F.; Meschia, M.; Vercellini, P. “The first cut is the deepest”: A psychological, sexological and gynecological perspective on female genital cosmetic surgery. Acta Obstet. Gynecol. Scand. 2015, 94, 915–920. [Google Scholar] [CrossRef] [PubMed]
  37. Kimani, S.; Kabiru, C.W.; Muteshi, J.; Guyo, J. Exploring barriers to seeking health care among Kenyan Somali women with female genital mutilation: A qualitative study. BMC Int. Health Hum. Rights 2020. [Google Scholar] [CrossRef] [PubMed]
  38. Esu, E.; Okoye, I.; Arikpo, I.; Ejemot-Nwadiaro, R.; Meremikwu, M.M. Providing information to improve body image and care-seeking behavior of women and girls living with female genital mutilation: A systematic review and meta-analysis. Int. J. Gynaecol. Obstet. 2017, 136, 72–78. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Derogatis, L.R. SCL-90-R: Administration, Scoring and Procedures Manual; Clinical Psychology: Baltimore, MD, USA, 1990. [Google Scholar]
  40. Derogatis, L.R. SCL-90-R: Cuestionario de 90 Síntomas—Manual; TEA Ediciones: Madrid, Spain, 1994; pp. 1–47. [Google Scholar]
  41. Rosen, R.; Brown, C.; Heiman, J.; Leiblum, S.; Meston, C.; Shabsigh, R.; Ferguson, D.; D’Agostino, R. The female sexual function index (Fsfi): A multidimensional self-report instrument for the assessment of female sexual function. J. Sex. Marital Ther. 2000, 26, 191–205. [Google Scholar] [CrossRef] [PubMed]
  42. Blumel, J.E.; Binfa, L.; Cataldo, P.; Carrasco, A.; Izaguirre, H.; Sarrá, S. Female sexual function index: A test to evaluate sexuality in women. Rev. Chil. Obstet. Ginecol. 2004, 69, 118–125. [Google Scholar]
  43. Derogatis, L.; Clayton, A.; Lewis-D’agostino, D.; Wunderlich, G.; Fu, Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J. Sex. Med. 2008, 5, 357–364. [Google Scholar] [CrossRef]
  44. Del Barrio, V. Diagnostic and Statistical Manual of Mental Disorders; American Psychiatric Association: Washington, DC, USA, 2016; ISBN 9780128093245. [Google Scholar]
  45. Cooper, P.J.; Taylor, M.J.; Cooper, Z.; Fairbum, C.G. The development and validation of the body shape questionnaire. Int. J. Eat. Disord. 1987, 6, 485–494. [Google Scholar] [CrossRef]
  46. Raich, R.M.; Mora, M.; Soler, A.; Avila, C.; Clos, I.; Zapater, L. Adaptación de un instrumento de evaluación de la insatisfacción corporal. Clin. Salud 1996, 7, 51–66. [Google Scholar]
  47. Herbenick, D.; Reece, M. Original research—outcomes assessment: Development and validation of the female genital self-image scale. J. Sex. Med. 2010, 7, 1822–1830. [Google Scholar] [CrossRef] [PubMed]
  48. Davidson, J. Davidson Trauma Scale; Multi-Health Systems: North Tonawanda, NY, USA, 1996. [Google Scholar]
  49. Abdulcadir, J.; Bianchi-Demicheli, F.; Petignat, P. Sexual function and clitoral reconstruction after female genital mutilation. Rev. Med. Suisse 2017, 13, 597–601. [Google Scholar]
  50. Thabet, S.M.A.; Thabet, A.S.M.A. Defective sexuality and female circumcision: The cause and the possible management. J. Obstet. Gynaecol. Res. 2003, 29, 12–19. [Google Scholar] [CrossRef] [PubMed]
  51. Berg, R.C.; Taraldsen, S.; Said, M.A.; Sørbye, I.K.; Vangen, S. The effectiveness of surgical interventions for women with FGM/C: A systematic review. BJOG An. Int. J. Obstet. Gynaecol. 2018, 125, 278–287. [Google Scholar] [CrossRef] [PubMed]
  52. Bramwell, R.; Morland, C. Genital appearance satisfaction in women: The development of a questionnaire and exploration of correlates. J. Reprod. Infant Psychol. 2009, 27, 15–27. [Google Scholar] [CrossRef]
  53. Pazmany, E.; Bergeron, S.; Van Oudenhove, L.; Verhaeghe, J.; Enzlin, P. Body image and genital self-image in pre-menopausal women with dyspareunia. Arch. Sex. Behav. 2013, 42, 999–1010. [Google Scholar] [CrossRef] [PubMed]
  54. Demaria, A.L.; Hollub, A.V.; Herbenick, D. Using genital self-image, body image, and sexual behaviors to predict gynecological exam behaviors of college women. J. Sex. Med. 2011, 8, 2484–2492. [Google Scholar] [CrossRef]
  55. Sharif Mohamed, F.; Wild, V.; Earp, B.D.; Johnson-Agbakwu, C.; Abdulcadir, J. Clitoral reconstruction after female genital mutilation/cutting: A review of surgical techniques and ethical debate. J. Sex. Med. 2020, 17, 531–542. [Google Scholar] [CrossRef]
Figure 1. Clinical procedure timeline.
Figure 1. Clinical procedure timeline.
Jcm 09 02340 g001
Table 1. Sample characteristics.
Table 1. Sample characteristics.
Country of BirthN%
Spain321.5
Gambia17.2
Ethiopia17.2
Mali214.2
Guinea321.5
Senegal214.2
Ivory Coast214.2
Total14100
Family StatusN%
single1173.3
married/relationship320.0
separated16.7
Total15100
ChildrenN%
none1173.3
1213.3
2213.3
Total15100
EducationN%
elementary school213.3
high school746.7
higher education640.0
Total15100
OccupationN%
employed1066.7
student213.3
unemployed320.0
Total15100
Current Sexual ActivityN%
yes861.5
no538.5
Total13100
Mutilation typeN%
Type I213.3
Type II1386.7
Total15100.0
Psychiatric HistoryN%
none1386.7
anxiety16.7
other16.7
Total15100
Table 2. Rates of DSM-5 sexual disorders among women in the longitudinal cohort.
Table 2. Rates of DSM-5 sexual disorders among women in the longitudinal cohort.
DSM-5 Disorders
Sexual interest or arousal disorderN%
Yes853.3
No746.7
Total15100.0
Orgasmic disorderN%
Yes1066.7
No533.3
Total15100.0
Genito-pelvic pain or penetration disorderN%
Yes533.3
No1066.7
Total15100.0
Table 3. Comparison between baseline measures (pre) and post-operative measures (one year, post) with regard to psychological well-being, sexual distress, sexual function, body image and genital self-image in women who suffered FGM/C.
Table 3. Comparison between baseline measures (pre) and post-operative measures (one year, post) with regard to psychological well-being, sexual distress, sexual function, body image and genital self-image in women who suffered FGM/C.
QuestionnairesNMeanStd. DeviationPCohen’s d
SCL-90-R
SCL Somatization pre151.210.91
post150.820.820.020.68
SCL Obsessive Compulsive pre151.791.07
post151.250.920.110.44
SCL Interpersonal Sensitivity pre151.581.12
post150.960.900.010.74
SCL Depression pre151.631.19
post151.051.070.050.56
SCL Anxiety pre151.231.06
post 150.830.960.140.40
SCL Hostility pre151.021.06
post150.661.020.190.35
SCL Phobic Anxiety pre150.981.23
post150.430.680.020.71
SCL Paranoid Ideation pre151.561.13
post150.921.110.030.63
SCL Psychoticism pre151.181.10
post150.700.950.080.49
SCL Global Severity Index pre151.430.93
post150.900.860.020.69
SCL Positive Symptom Total pre1549.1325.46
post1535.7324.870.040.58
SCL Positive Symptom Distress Index pre152.260.80
post151.830.810.020.65
FSDS-R
FSDS-R pre1528.9314.44
post1512.9313.30p < 0.0011.22
FSFI
FSFI Desire pre154.632.62
post154.361.770.740.09
FSFI Arousal pre155.395.20
post154.204.830.490.18
FSFI Lubrication pre157.267.77
post153.885.010.140.40
FSFI Orgasm pre153.894.14
post152.963.870.380.24
FSFI Satisfaction pre154.613.47
post154.353.290.780.08
FSFI Pain pre154.115.33
post154.033.680.950.02
FSFI Total pre1529.1623.79
post1523.8421.570.440.21
BSQ
BSQ pre1593.6748.54
post1581.3357.980.200.35
FGSI
FGSI pre1514.275.35
post1520.406.450.02−0.71

Share and Cite

MDPI and ACS Style

Paslakis, G.; Farré, J.M.; Tolosa-Sola, I.; Palazón-Llecha, A.; Domínguez-Cagnon, H.; Jiménez, M.; Martínez Rosselló, B.; Barri-Soldevila, P.; Mestre-Bach, G. Clinical Features Associated with Female Genital Mutilation/Cutting: A Pilot Longitudinal Study. J. Clin. Med. 2020, 9, 2340. https://doi.org/10.3390/jcm9082340

AMA Style

Paslakis G, Farré JM, Tolosa-Sola I, Palazón-Llecha A, Domínguez-Cagnon H, Jiménez M, Martínez Rosselló B, Barri-Soldevila P, Mestre-Bach G. Clinical Features Associated with Female Genital Mutilation/Cutting: A Pilot Longitudinal Study. Journal of Clinical Medicine. 2020; 9(8):2340. https://doi.org/10.3390/jcm9082340

Chicago/Turabian Style

Paslakis, Georgios, Josep M. Farré, Iris Tolosa-Sola, Alba Palazón-Llecha, Helena Domínguez-Cagnon, Maria Jiménez, Berta Martínez Rosselló, Pere Barri-Soldevila, and Gemma Mestre-Bach. 2020. "Clinical Features Associated with Female Genital Mutilation/Cutting: A Pilot Longitudinal Study" Journal of Clinical Medicine 9, no. 8: 2340. https://doi.org/10.3390/jcm9082340

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop